Microvascular Angina Clinical Trials

11 recruiting

Microvascular Angina Trials at a Glance

12 actively recruiting trials for microvascular angina are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Seoul, London, and Basildon. Lead sponsors running microvascular angina studies include Centre Hospitalier Universitaire Dijon, China-Japan Friendship Hospital, and Catharina Ziekenhuis Eindhoven.

Browse microvascular angina trials by phase

Treatments under study

About Microvascular Angina Clinical Trials

Looking for clinical trials for Microvascular Angina? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Microvascular Angina trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Microvascular Angina clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

Non-invasive Diagnosis of Coronary Microvascular Disease: Pilot Study

Microvascular Angina
University of Leicester20 enrolled1 locationNCT06070662
Recruiting
Not Applicable

iCorMicA - Stratified Medicine in Angina

Coronary Microvascular Dysfunction (CMD)Angina, StableMicrovascular Angina+1 more
NHS Greater Glasgow and Clyde1,500 enrolled39 locationsNCT04674449
Recruiting

The Value of Measuring Retinal Vascular Density by Optical Coherence Tomography-Angiography (OCT-A) in Patients With Microvascular Angina Confirmed by Myocardial Microcirculatory Resistance Index (MRI).

Microvascular Angina
Centre Hospitalier Universitaire Dijon158 enrolled1 locationNCT06692751
Recruiting

Comprehensive Coronary Physiology in Patients With Angina With Nonobstructive Coronary Arteries - Czech Republic

Microvascular DysfunctionMicrovascular AnginaMINOCA+4 more
University Hospital, Motol1,000 enrolled1 locationNCT07103317
Recruiting
Not Applicable

Microvascular Coronary Rehabilitation For Improving Treatment - Feasibility Study

Coronary Microvascular Dysfunction (CMD)Microvascular Coronary DysfunctionMicrovascular Angina
Royal United Hospitals Bath NHS Foundation Trust40 enrolled2 locationsNCT06681896
Recruiting
Not Applicable

Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction.

Coronary DiseaseAngina PectorisMicrovascular Coronary Artery Disease+2 more
Imperial College London54 enrolled1 locationNCT05492110
Recruiting

Sex Difference of Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease

Microvascular Angina
Korea University Anam Hospital300 enrolled1 locationNCT06076551
Recruiting
Early Phase 1

Evaluation of the Efficacy of MACitentan in the Treatment of CoronaryMICrovascular Angina (MACMIC)

Coronary Microvascular AnginaMacitentan
China-Japan Friendship Hospital30 enrolled1 locationNCT06811831
Recruiting
Phase 2Phase 3

Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries

Angina PectorisMicrovascular AnginaVasospastic Angina+1 more
Stanford University150 enrolled1 locationNCT06424834
Recruiting
Not Applicable

Transcutaneous Electrical Nerve Stimulation in Patients With Angina and Non-Obstructive Coronary Arteries

Microvascular AnginaVasospastic Angina
Catharina Ziekenhuis Eindhoven20 enrolled1 locationNCT06401291
Recruiting

Relationship Between Coronary Microvascular Dysfunction and Improvement of Left Ventricular Systolic Function in Patients With Heart Failure With Reduced Ejection Fraction Caused by Non-ischemic Etiology

Heart FailureNon-ischemic CardiomyopathyMicrovascular Angina
Samsung Medical Center200 enrolled1 locationNCT06243653
Recruiting
Phase 4

Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)

Microvascular Angina
Qilu Hospital of Shandong University100 enrolled1 locationNCT06092736